false
0001952853
0001952853
2026-01-16
2026-01-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 16, 2026
| MASSIMO
GROUP |
| (Exact
name of registrant as specified in its charter) |
| Nevada |
|
001-41994 |
|
92-0790263 |
(State
or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
3101
W Miller Road
Garland, TX |
|
75041 |
| (Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code:
(877)
881-6376
| Not
applicable |
| (Former
name or former address, if changed since last report) |
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.001 per share |
|
MAMO |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
On
January 16, 2026, the Board of Directors (the “Board”) of Massimo Group (the “Company”) accepted Dr. Yunhao Chen’s
letter of resignation as Chief Financial Officer and director of the Company, effective as of January 16, 2026. Dr. Chen’s decision
to resign is not due to any disagreement with the Company, the Board, or any member of the Company’s management.
In
connection with this transition, the Board appointed Mr. David Shan, currently the Chief Executive Officer of the Company, to serve as
Interim Chief Financial Officer of the Company, effective immediately. The Company is currently undergoing a search for a permanent Chief
Financial Officer with appropriate experience.
There
are no arrangements or understandings between Mr. Shan and any other persons pursuant to which he was selected as Interim Chief Financial
Officer. Additionally, there are no transactions in which Mr. Shan has an interest requiring disclosure under Item 404(a) of Regulation
S-K.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.
| Dated:
January 23, 2026 |
MASSIMO
GROUP |
| |
|
|
| |
By: |
/s/
David Shan |
| |
Name: |
David
Shan |
| |
Title: |
Chief
Executive Officer |